NCT05276739 (LipidPRC) is a NA clinical trial of Bright Light in Light Exposure, sponsored by Brigham and Women's Hospital.

Who is sponsoring NCT05276739?

NCT05276739 is sponsored by Brigham and Women's Hospital.

What drugs are being tested in NCT05276739?

Interventions in NCT05276739: Bright Light, Time-restricted eating, Dim light, 12-h meal window.

What condition does NCT05276739 study?

NCT05276739 studies Light Exposure, Meal Timing.

Is NCT05276739 still recruiting?

NCT05276739 is currently status unknown. Last updated 7 June 2023.

Last reviewed 2023-06-07 · How we verify

NCT05276739: LipidPRC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Photic and Non-photic Time Cues in Resetting Circadian Rhythms

Status unknown NA Last updated 7 June 2023

What this trial tests

NA trial testing Bright Light in Light Exposure in 48 participants. Status unknown.

Timeline

29 July 2022

Primary endpoint
30 March 2025

30 September 2025

Quick facts

Lead sponsor	Brigham and Women's Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	48
Start date	29 July 2022
Primary completion	30 March 2025
Estimated completion	30 September 2025
Sites	1 location across United States

Drugs / interventions tested

Bright Light
Time-restricted eating
Dim light
12-h meal window

Conditions studied

Light Exposure — all drugs for Light Exposure →
Meal Timing — all drugs for Meal Timing →

Sponsor

Brigham and Women's Hospital

Who can join

Adults 18 to 30, any sex, with Light Exposure or Meal Timing. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine the principal time cue (light or meals) for resetting circadian rhythms in melatonin and metabolic outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bright Light

Trials testing the same drug.

NCT03331822 — The Effects of Bright Light Exposure on ICU Nurses · NA · completed
NCT03188263 — Morning Light Treatment to Improve Glucose Metabolism · NA · completed

Other recruiting trials for Light Exposure

Currently open trials in the same condition.

NCT07329283 — Nighttime Synchrony of Your Nutrition and Circadian Health · NA · recruiting

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05276739 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
Last refreshed: 7 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05276739.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing